PAI
MLNT

Palo Alto Investors’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Palo Alto Investors’s Portfolio MLNT Stock Details MLNT Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
2019
Q4 		$5K Hold
2019
Q3 		$39K Hold
2019
Q2 		$67K Hold
2019
Q1 		$36K Sell
2018
Q4 		$40K Hold
2018
Q3 		$200K Hold
2018
Q2 		$322K Hold
2018
Q1 		$375K Hold
2017
Q4 		$801K Buy